Abstract:Editorial Office Annals of Translational Medicine Submitted Jul 21, 2024. Accepted for publication Aug 02, 2024. Published online Sep 05, 2024. doi: 10.21037/atm-2024-9 Erratum to: Ann Transl Med 2021;9:533 The article (1) titled "ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway" (doi: 10.21037/atm-20-7005), unfortunately contains several errors that need to be corrected. The image in the upper right corner of Figure 2F, which represents the migration of the control shRNA-expressing MDA-MB-231 cells, was selected incorrectly. This image should be replaced with the correct one. In the legend of Figure 2, the order of the parts corresponding to Figure 2E-2I was incorrect. The correct order is: (E) colony formation assay on MDA-MB-231; (F) migration assay on MDA-MB-231; (G) migration assay on MDA-MB-468; (H) invasion assay on MDA-MB-231; (I) invasion assay on MDA-MB-468. The caption "MDA-MB-468" in Figure 4 was accidentally misplaced between Figure 4D and Figure 4F, which should be at the bottom of Figure 4C . In the legend of Figure 4, the order of the parts corresponding to Figure 4C-4F was incorrect. The correct order is: (C) CCK-8 assay on MDA-MB-468; (D) migration assay on MDA-MB-231; (E) migration assay on MDA-MB-468; (F) invasion assay on MDA-MB-231. Figure 2F in the original article: The legend of Figure 2 in the original article: Caption "MDA-MB-468" in Figure 4 in the original article: The legend of Figure 4 in the original article: The updated version of Figure 2 , containing the correct image for the "Control" in Figure 2F , and the updated version of Figure 4 with the correct position of the caption "MDA-MB-468", together with the correct legends for both figures, are shown below. These errors did not significantly affect either the results or the conclusions of the paper. Click here to view the updated version of the article. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

Erratum to PITPNC1 fuels radioresistance of rectal cancer by inhibiting reactive oxygen species production

Erratum to erratum to miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expression

Erratum to ESM1 promotes triple-negative breast cancer cell proliferation through activating AKT/NF-κB/Cyclin D1 pathway

Erratum: Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma

Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Retraction: Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signaling

Erratum to MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8

[Erratum] Oxidative stress, autophagy and pyroptosis in the neovascularization of oxygen‐induced retinopathy in mice

Erratum: Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming: Erratum

[Corrigendum] PRIMA‐1 met induces autophagy in colorectal cancer cells through upregulation of the mTOR/AMPK‐ULK1‐Vps34 signaling cascade

Erratum to preoperative prediction of gastrointestinal stromal tumors with high Ki-67 proliferation index based on CT features

[Corrigendum] Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells

Erratum to MiR-140-5p targets Prox1 to regulate the proliferation and differentiation of neural stem cells through the ERK/MAPK signaling pathway

[Retracted] Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS‐mutated lung cancer cells

Retraction notice to “PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages” [Cancer Lett. 529 (2022) 19–36]

Erratum to "Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation"

Corrigendum To: "pkcα/zfp64/csf1 Axis Resets the Tumor Microenvironment and Fuels Anti-Pd1 Resistance in Hepatocellular Carcinoma" [J Hepatol 77 (2022) 163-176].

Erratum to maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)

Erratum: the PI 3-Kinase/akt Signaling Pathway is Activated Due to Aberrant Pten Expression and Targets Transcription Factors NF-κB and C-Myc in Pancreatic Cancer Cells

[Corrigendum] Resveratrol reverses P‐glycoprotein‐mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF‐κB and p38 MAPK signaling pathways